GSK · 10000+ people · Public
Senior Director, Cardiovascular and Metabolic Diseases, Clinical Pharmacology Modeling and Simulation
- Baar Onyx
- Hybrid
- US$222,750 – US$371,250 pa
- Director
Leads end-to-end Model-Informed Drug Development and clinical pharmacology strategy across the drug development lifecycle, from first-in-human studies through filing and lifecycle management. Coordinates CPMS activities across assets, approves study designs and regulatory documents, and partners with digital medicine, translational imaging and modelling specialists. Reports into the Respiratory, Immunology & Inflammation Research Unit within the new CPQM organisation.
MIDD · QSP · AI/ML